Search results
Results from the WOW.Com Content Network
Johnson & Johnson (J&J) has reached a A$300 million ($204.90 million) settlement in two Australian class action suits filed by Shine Lawyers for selling defective pelvic mesh implants to ...
Johnson & Johnson (NYSE: JNJ) has reached a A$300 million settlement in two Australian class action suits filed by Shine Lawyers for selling defective pelvic mesh implants to Australian women. The ...
For premium support please call: 800-290-4726 more ways to reach us
Transvaginal mesh (TVM) has a greater risk of bladder injury and of needing repeat surgery for stress urinary incontinence or mesh exposure. [17] The use of a TVM in treating vaginal prolapses is associated with severe side effects including organ perforation, infection, and pain. Safety and efficacy of many newer meshes is unknown. [16]
Transvaginal mesh, also known as vaginal mesh implant, is a net-like surgical tool that is used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) among female patients. The surgical mesh is placed transvaginally to reconstruct weakened pelvic muscle walls and to support the urethra or bladder.
Generally, mesh may be considered in instances where the connective tissue is weak or absent, if there is an empty space at the surgical site that needs to be bridged, or if there is a high risk of prolapse recurrence. [2] Synthetic mesh is indicated and used for sacrocolpopexy and sacrohysteropexy procedures. [2]
Plaintiffs in the pelvic mesh litigation have accused a Johnson & Johnson subsidiary of judge-shopping after the company asked a Philadelphia judge to recuse from an upcoming trial and also sought ...
Colposacropexy is often used for treating vaginal vault prolapse. A Cochrane Collaboration review [ needs update ] found that limited data are available on optimal surgical approaches, including the use of transvaginal surgical mesh devices, in the form of a patch or sling , similar to its implementation for abdominal hernia .